In contrast, levels of all remaining examples above except CNTN5, contributed in multi-protein models also including acute stroke severity, suggesting that there is a time-window early post-stroke where plasma levels of some proteins reflect biological processes that influence long-term cognitive outcome independent of stroke severity. This evidence concerns the gene CNTN5 and stroke disorder.